Concepedia

John Amerena

JA

Statistics

Publications

56

Citations

5.8K

H-Index

34

Active since

1994

Affiliations

The University of Melbourne(Current)

Geelong Hospital

Deakin University

Monash University

John Amerena is an author at The University of Melbourne specializing in medicine, cardiology, and cardiovascular pharmacotherapy.

Publications per year

1994–2025

56

Publications

56

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas et al. · European Heart Journal · 2012 · 573 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Colchicine in Patients With Acute Coronary Syndrome

David Tong, Stephen Quinn, Arthur Nasis et al. · Circulation · 2020 · 379 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

Stuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz et al. · Circulation · 2013 · 218 citations · Full text

Medicine, Cardiology, Pharmacology +15

1–5 of 56